Dark
Streaming/Mobile
OldĀ Site
Home
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
12:09:20 EDT Thu 12 Jun 2025
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR Search
SEDAR Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login to Stockwatch
Q:VTRS
- VIATRIS INC -
https://www.viatris.com
12:09:20 EDT
Sym-X
Bid - Ask
Last
Chg
%Ch
Vol
$Vol
#Tr
Open-Hi-Lo
Year Hi-Lo
Last Tr
News
Delay
VTRS
- Q
5.3
9.07
·
9.08
5.3
9.075
+0.095
1.1
4,860.6
43,234
11,587
8.955
9.19
8.92
13.55 6.85
11:53:03
Jun 02
15 min
RT 2¢
Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market:
Nasdaq
-- Bid Tick:
Up
-- UPC Restricted:
No
Fundamentals
·
Holders
·
Trade Workstation
·
Market Depth
·
3 Month Closes
·
Technical Charts
1 yr
|
2 yr
|
3 yr
|
5 yr
|
10 yr
|
15 yr
|
20 yr
·
Live Charts
1 yr
|
1 day
·
1yr Bulletins
·
Historical
·
Options
·
Portfolio
Recent Trades - Last 10 of 11587
More trades...
Time ET
Ex
Price
Change
Volume
11:53:12
Q
9.0706
0.0906
100
11:53:12
Q
9.07
0.09
1,636
11:53:09
Q
9.08
0.10
356
11:53:09
Q
9.075
0.095
1
11:53:09
Q
9.0746
0.0946
1
11:53:07
Q
9.07
0.09
30
11:53:07
Q
9.075
0.095
5
11:53:07
Q
9.07
0.09
70
11:53:04
Q
9.075
0.095
100
11:53:03
Q
9.075
0.095
6
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
Recent Bulletins
News Releases
In The News
Other
Date ET
Symbol
Type
Headline
2025-06-02 08:00
U:VTRS
News Release
200
Viatris Announces Positive Top-Line Results from Phase 3 LYNX-2 Trial of MR-142 in Keratorefractive Patients With Visual Disturbances Under Mesopic, Low-Contrast Conditions
2025-05-27 06:59
U:VTRS
News Release
200
Viatris Announces Launch of First Clozapine Orally Disintegrating Tablet (ODT) in Canada
2025-05-22 06:59
U:VTRS
News Release
200
Viatris to Participate in Upcoming Investor Conferences
2025-05-08 06:59
U:VTRS
News Release
200
Viatris Reports First Quarter 2025 Results and Reaffirms 2025 Outlook
2025-05-08 06:45
U:VTRS
News Release
200
Viatris Announces Positive Results from Phase 3 Study of Investigational XULANE LO(TM) Low Dose Patch for Birth Control in Women of Childbearing Potential
2025-05-08 06:30
U:VTRS
News Release
200
Viatris Announces Positive Top-Line Results from Two Pivotal Phase 3 Studies of Novel Fast-Acting Meloxicam (MR-107A-02) for the Treatment of Moderate-to-Severe Acute Pain
2025-05-07 06:59
U:VTRS
News Release
200
Viatris Announces Quarterly Dividend
2025-05-05 16:30
U:VTRS
News Release
200
Viatris Announces Appointments of Frank D'Amelio and Michael Severino, M.D., to the Company's Board of Directors
2025-04-25 06:59
U:VTRS
News Release
200
Viatris to Present at the BofA Securities 2025 Healthcare Conference
2025-04-21 06:59
U:VTRS
News Release
200
Viatris Files Supplemental New Drug Applications to Japan's Ministry of Health, Labor and Welfare for the Approval of EFFEXOR(TM) for the Treatment of Generalized Anxiety Disorder
2025-04-14 06:59
U:VTRS
News Release
200
Viatris Appoints Hemanth J. Varghese as Chief Strategy Officer
2025-04-07 06:59
U:VTRS
News Release
200
Viatris Statement on Nationwide Settlement to Resolve Opioid-Related Claims
2025-03-28 06:59
U:VTRS
News Release
200
Viatris to Report First Quarter 2025 Financial Results on May 8, 2025
2025-03-05 16:30
U:VTRS
News Release
200
Viatris to Present at the Barclays 27th Annual Global Healthcare Conference
2025-02-27 06:45
U:VTRS
News Release
200
Viatris Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Financial Guidance
2025-02-27 06:30
U:VTRS
News Release
200
Viatris Maintains Dividend Policy for 2025 and Announces Quarterly Dividend
2025-02-19 10:49
U:VTRS
News Release
200
Uniting Against AMR: Global Solutions Need Local and Global Collaboration
2025-02-17 17:00
U:VTRS
News Release
200
50 Years of Service: From Milkman's Son to Advancing Access to Medicines
2025-02-03 16:30
U:VTRS
News Release
200
Viatris to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
2025-01-07 06:59
U:VTRS
News Release
200
Viatris to Present at the 43rd Annual J.P. Morgan Healthcare Conference